Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-11 Sale | 2026-08-13 4:11 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 20,000 | $57.75 | $1,155,055 | 348,436 (Direct) | View |
| 2023-06-05 Sale | 2023-06-07 6:32 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 10,000 | $54.89 | $548,894 | 333,736 (Direct) | View |
| 2021-12-30 Sale | 2022-01-04 6:13 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $150.92 | $754,590 | 341,616 (Direct) | View |
| 2021-12-01 Sale | 2021-12-03 5:51 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $151.16 | $755,820 | 346,616 (Direct) | View |
| 2021-11-16 Sale | 2021-11-18 7:47 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $158.83 | $794,166 | 351,616 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 7:13 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $163.51 | $817,567 | 356,616 (Direct) | View |
| 2021-10-18 Sale | 2021-10-20 5:39 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $150.67 | $753,343 | 361,616 (Direct) | View |
| 2021-10-07 Sale | 2021-10-12 4:15 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $150.18 | $750,899 | 366,616 (Direct) | View |
| 2021-09-16 Sale | 2021-09-20 7:26 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $156.33 | $781,668 | 371,616 (Direct) | View |
| 2021-09-01 Sale | 2021-09-03 7:55 pm | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 5,000 | $177.48 | $887,411 | 376,616 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-04 Option Award | 2026-06-08 7:26 pm | N/A N/A | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 8,829 | $0 | 368,436 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 5:22 pm | N/A N/A | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 15,357 | $0 | 359,607 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 4:26 pm | N/A N/A | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 8,649 | $0 | 344,250 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:42 pm | N/A 2033-06-14 | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 6,526 | $0 | 340,262 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:18 pm | N/A 2032-06-15 | 10x Genomics Inc. | TXG | STUELPNAGEL JOHN R Director | 7,420 | $0 | 349,036 (Direct) | View |